"Centro Oncológico con Expertos en el manejo del Cáncer, inmunoterapia, terapias anti hormonales de tercera generación, quimioterapia tradicional, PROTOCOLOS de investigación, Consejo Genético, Expertos en Radioterapia de precisión, CIBERKNIFE, Tomoterapia, IMRT, etc"

During the past decade, i Can Oncology Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "i Can Oncology Center" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials), "Neoplasms" (1 trials), "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "i Can Oncology Center" in a lesser frequency.

Most popular intervention types in "i Can Oncology Center" are "Drug" (7 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (2 trials), "Placebo" (2 trials), "ADT (Standard of Care)" (1 trials), "Abiraterone acetate (AA)" (1 trials) and "Apalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "i Can Oncology Center" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "i Can Oncology Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in i Can Oncology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in i Can Oncology Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".